|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,830,000 |
Market
Cap: |
3.78(B) |
Last
Volume: |
581,366 |
Avg
Vol: |
694,871 |
52
Week Range: |
$39.75 - $67.51 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 443 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
12,975 |
Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
39,197 |
39,197 |
Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,183,306 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
5 |
5 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Tenney Maurice H. |
President-Brooks Life Sciences |
|
2018-11-16 |
4 |
S |
$28.59 |
$98,950 |
D/D |
(3,461) |
138,969 |
|
- |
|
Jarzynka David |
Sr. VP, General Manager |
|
2018-11-16 |
4 |
S |
$28.35 |
$143,986 |
D/D |
(5,058) |
87,680 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2018-11-16 |
4 |
S |
$28.59 |
$29,962 |
D/D |
(1,048) |
40,284 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2018-11-13 |
4 |
AS |
$29.04 |
$296,992 |
D/D |
(10,227) |
61,482 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2018-11-12 |
4 |
S |
$30.93 |
$1,238,437 |
D/D |
(40,040) |
132,553 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2018-11-12 |
4 |
S |
$30.93 |
$2,932,968 |
D/D |
(94,826) |
502,211 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2018-11-12 |
4 |
S |
$30.93 |
$306,176 |
D/D |
(9,899) |
41,332 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2018-11-12 |
4 |
AS |
$30.93 |
$740,031 |
D/D |
(23,926) |
71,709 |
|
- |
|
Tenney Maurice H. |
President-Brooks Life Sciences |
|
2018-11-12 |
4 |
S |
$30.93 |
$1,437,843 |
D/D |
(46,487) |
142,430 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2018-11-12 |
4 |
S |
$30.93 |
$640,375 |
D/D |
(20,704) |
108,398 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2018-11-12 |
4 |
S |
$30.93 |
$640,375 |
D/D |
(20,704) |
86,708 |
|
- |
|
Jarzynka David |
Sr. VP, General Manager |
|
2018-11-12 |
4 |
S |
$30.93 |
$862,823 |
D/D |
(27,896) |
17,760 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2018-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
21,570 |
129,102 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2018-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
37,747 |
172,593 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2018-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
21,570 |
107,412 |
|
- |
|
Jarzynka David |
Sr. VP, General Manager |
|
2018-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
24,265 |
45,656 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2018-11-06 |
4 |
AS |
$31.79 |
$24,764 |
D/D |
(779) |
95,635 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2018-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
24,265 |
114,917 |
|
- |
|
Tenney Maurice H. |
President-Brooks Life Sciences |
|
2018-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
43,140 |
188,917 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2018-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
83,582 |
597,037 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2018-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,132 |
51,231 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2018-11-05 |
4 |
S |
$31.76 |
$32,586 |
D/D |
(1,026) |
107,532 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2018-11-05 |
4 |
S |
$31.76 |
$57,041 |
D/D |
(1,796) |
134,846 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2018-11-05 |
4 |
S |
$31.76 |
$32,586 |
D/D |
(1,026) |
85,842 |
|
- |
|
Jarzynka David |
Sr. VP, General Manager |
|
2018-11-05 |
4 |
S |
$31.76 |
$52,753 |
D/D |
(1,661) |
21,391 |
|
- |
|
1054 Records found
|
|
Page 13 of 43 |
|
|